Abstract:The cell cycle is the sequence of events orchestrated by a complex network of cell cycle proteins. Unlike normal cells, mature neurons subsist in a quiescent state of the cell cycle, and aberrant cell cycle activation triggers neuronal death accompanied by neurodegeneration. The periodicity of cell cycle events is choreographed by various mechanisms, including DNA damage repair, oxidative stress, neurotrophin activity, and ubiquitin-mediated degradation. Given the relevance of cell cycle processes in cancer and neurodegeneration, this review delineates the overlapping cell cycle events, signaling pathways, and mechanisms associated with cell cycle aberrations in cancer and the major neurodegenerative disorders. We suggest that dysregulation of some common fundamental signaling processes triggers anomalous cell cycle activation in cancer cells and neurons. We discussed the possible use of cell cycle inhibitors for neurodegenerative disorders and described the associated challenges. We propose that a greater understanding of the common mechanisms driving cell cycle aberrations in cancer and neurodegenerative disorders will open a new avenue for the development of repurposed drugs.Graphical AbstractCell cycle activation and cell cycle re-entry are the two critical cellular phenomena associated with cancer and neurodegeneration, respectively. Various regulatory proteins, such as cyclin-dependent kinases (CDKs), cyclins, and checkpoint kinases, control the cell cycle dynamics at different phases. Further, the integrity of cell cycle is controlled by different mechanisms like DNA damage response, oxidative stress, neurotrophin activity, and the ubiquitin–proteasome system (UPS), the alterations which play an essential role in the pathogenesis of both cancer and neurodegenerative disorders. Pharmacological targeting of important cell cycle regulatory molecules like the application of CDK inhibitors, PARP inhibitors, checkpoint kinase inhibitors, and microtubule inhibitors holds great promise for treating various human cancers and can be repurposed for different neurodegenerative disorders.

DEAD-Box RNA Helicases in Cell Cycle Control and Clinical Therapy

Regulation and mechanisms of action of RNA helicases

The roles of RNA helicases in DNA damage repair and tumorigenesis reveal precision therapeutic strategies

Circular RNAs in cell cycle regulation: Mechanisms to clinical significance

R-loop and diseases: the cell cycle matters

The DEAD-box RNA helicase 51 controls non-small cell lung cancer proliferation by regulating cell cycle progression via multiple pathways

Cell Cycle Regulation and Hematologic Malignancies

DEAD Box RNA Helicases: Biochemical Properties, Role in RNA Processing and Ribosome Biogenesis

Current understanding of the role of DDX21 in orchestrating gene expression in health and diseases

Protective Role of RNA Helicase DEAD-Box Protein 5 in Smooth Muscle Cell Proliferation and Vascular Remodeling

RNA-based Therapeutics: an Overview and Prospectus

Cell Cycle-Related Lncrnas As Innovative Targets to Advance Cancer Management

Circular RNA Controls Tumor Occurrence and Development Via Cell Cycle Regulation

Cell cycle regulation and anticancer drug discovery

Post-transcriptional regulation of DEAD-Box RNA helicases in hematopoietic malignancies

DEAD-box RNA helicases in the multistep process of tumor metastasis

Effects of DDX Family on Cancer Development and Progression

DEAD/H-Box Helicases in Immunity, Inflammation, Cell Differentiation, and Cell Death and Disease

Biological functions of DEAD/DEAH-box RNA helicases in health and disease

Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs

DEAD/H-box Helicases:Anti-Viral and Pro-Viral Roles During Infections